Back
Harrow 10K Form
Buy
54
HROW
Harrow
Last Price:
13.21
Seasonality Move:
20.71%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HROW News And Ratings
See the #1 stock for the next 7 days that we like better than HROW
HROW Financial Statistics
Sales & Book Value
Annual Sales: | $130.19M |
---|---|
Cash Flow: | $8.49M |
Price / Cash Flow: | 0 |
Annual Sales: | $2.01 |
Price / Book: | 6.6 |
Profitability
EPS (TTM): | -0.76000 |
---|---|
Net Income (TTM): | $-24.41M |
Gross Margin: | $90.55M |
Return on Equity: | -56.34% |
Return on Assets: | -10.2% |
Harrow Earnings Forecast
Key Harrow Financial Ratios
- The Gross Profit Margin over the past 17 years for HROW is 69.55%.
- The Selling, General & Administrative Expenses for HROW have been equal to 63.82% of Gross Profit Margin.
- The Research & Development expenses have been 5.11% of Revenue.
- The Interest Expense is -87.35% of Operating Income.
- The Net Earning history of HROW is -18.75% of Total Revenues.
- Per Share Earnings over the last 18 years have been positive in 9 years.
Harrow Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Drug Manufacturers - Specialty & Generic |
Sector: | Healthcare |
Current Symbol: | HROW |
CUSIP: | 415858 |
Website: | harrow.com |
Debt
Debt-to-Equity Ratio: | 2.59 |
---|---|
Current Ratio: | 2.83 |
Quick Ratio: | 2.42 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 21.31 |